Glenside, PA, United States of America

Harry Sowden

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Kenvue Brands LLC. Active years: 2026.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry Sowden

Introduction

Harry Sowden is an accomplished inventor based in Glenside, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work has led to the creation of a unique tablet design that enhances the effectiveness of medication delivery.

Latest Patents

Harry Sowden holds a patent for "Tablets having discontinuous coated regions." This patent describes a dosage form that comprises a tablet core and one or more discontinuous coated regions in various configurations on the surface of the dosage form. The patent also outlines a method for making this innovative dosage form, which aims to improve the efficacy of medications.

Career Highlights

Sowden is currently employed at Kenvue Brands LLC, where he continues to work on advancing pharmaceutical technologies. His expertise in creating effective dosage forms has positioned him as a valuable asset to his company and the industry at large.

Collaborations

Throughout his career, Harry has collaborated with notable colleagues, including Gerard Mcnally and Der-Yang Lee. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas in the pharmaceutical sector.

Conclusion

Harry Sowden's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his commitment to improving medication delivery systems. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…